Preparing for an aging world: Engaging biogerontologists, geriatricians, and the society

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 71, Issue 4, 2016, Pages 435-444

  Nikolich Žugich, Janko ^a,b,c,d   Goldman, Dana P ^c   Cohen, Paul R ^d   Cortese, Denis ^e   Fontana, Luigi ^f,g,h   Kennedy, Brian K ⁱ   Mohler, M Jane ^a   Olshansky, S Jay ^j   Perls, Thomas ^k   Perry, Daniel ^l   Richardson, Arlan ^m   Ritchie, Christine ⁿ   Wertheimer, Anne M ^a   Faragher, Richard G A ^o   Fain, Mindy J ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Department of Immunobiology ^*  (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d University of Arizona   (United States)

^e ARIZONA STATE UNIVERSITY   (United States)

^f WASHINGTON UNIVERSITY   (United States)

^g UNIVERSITY OF BRESCIA   (Italy)

^h CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

ⁱ BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^j UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^k BOSTON MEDICAL CENTER   (United States)

^l Alliance for Aging Research   (United States)

^m UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF BRIGHTON   (United Kingdom)

more..

Author keywords

Healthspan; Longevity dividend; Models of care

Indexed keywords

AGED; AGING; DEMOGRAPHY; ELDERLY CARE; FEMALE; GERIATRICS; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; LIFE EXPECTANCY; LONGEVITY; MALE; PATHOLOGY; PHYSIOLOGY; QUALITY OF LIFE; TRANSLATIONAL RESEARCH; TRENDS;

AGED; AGING; DEMOGRAPHY; FEMALE; GERIATRICS; HEALTH PROMOTION; HEALTH SERVICES FOR THE AGED; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; LIFE EXPECTANCY; LONGEVITY; MALE; QUALITY OF LIFE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84964822899     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv164     Document Type: Review

References (68)

1. Group Avisory Council on Ageing Society. Global ageing population: Peril or promise? In: World Economic Forum, 2012. http://www.sjayolshansky.com/sjo/Background-files/WEF%20Book.pdf.
2. https://www.nia.nih.gov/research/announcements/2013/06/nih-host-october-2013-geroscience-summit3.
3. Olshansky SJ, Perry D, Miller RA, Butler RN. Pursuing the longevity dividend: scientific goals for an aging world. Ann N Y Acad Sci. 2007;1114:11-13.
4. Goldman DP, Cutler D, Rowe JW, et al. Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood). 2013;32:1698-1705. doi:10.1377/hlthaff.2013.0052.
5. Cortese D. Integrated health systems. In Rouse WB, Cortese DA, ed. Engineering the System of Healthcare Delivery. Amsterdam: IOS Press; 2008:369-382.
6. O'Kane M, Corrigan J, Foote SM, et al. Crossroads in quality. Health Aff (Millwood). 2008;27:749-758.
7. Cryer L, Shannon SB, Van Amsterdam M, Leff B. Costs for 'hospital at home' patients were 19 percent lower, with equal or better outcomes compared to similar inpatients. Health Aff (Millwood). 2012;31:1237-1243. doi:10.1377/hlthaff.2011.1132.
8. Butler RN, Miller RA, Perry D, et al. New model of health promotion and disease prevention for the 21st century. BMJ. 2008;337:a399. doi:10.1136/bmj.a399.
9. Hamerman D. Can biogerontologists and geriatricians unite to apply aging science to health care in the decade ahead? J Gerontol A Biol Sci Med Sci. 2010;65:1193-1197. doi:10.1093/gerona/glq117.
10. Burch JB, Augustine AD, Frieden LA, et al. Advances in geroscience: impact on healthspan and chronic disease. J Gerontol A Biol Sci Med Sci. 2014;69(suppl 1):S1-S3. doi:10.1093/gerona/glu041.
11. Howcroft TK, Campisi J, Louis GB, et al. The role of inflammation in agerelated disease. Aging (Albany NY). 2013;5:84-93.
12. Seals DR, Melov S. Translational geroscience: Emphasizing function to achieve optimal longevity. Aging (Albany NY). 2014;6:718-730.
13. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age- Associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(suppl 1):S4-S9. doi:10.1093/gerona/glu057.
14. Kennedy BK, Berger SL, Brunet A, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159:709-713. doi:10.1016/j.cell.2014.10.039.
15. Olshansky SJ, Martin GM, Kirland JL. Aging: The longevity dividend. 2016.
16. Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014;69:640-649.
17. Andersen SL, Sebastiani P, Dworkis DA, Feldman L, Perls TT. Health span approximates life span among many supercentenarians: compression of morbidity at the approximate limit of life span. J Gerontol A Biol Sci Med Sci. 2012;67:395-405. doi:10.1093/gerona/glr223.
18. Sebastiani P, Solovieff N, Dewan AT, et al. Genetic signatures of exceptional longevity in humans. PLoS One. 2012;7:e29848. doi:10.1371/journal.pone.0029848.
19. Sebastiani P, Sun FX, Andersen SL, et al. Families enriched for exceptional longevity also have increased health-span: findings from the long life family study. Front Public Health. 2013;1:38. doi:10.3389/fpubh.2013.00038.
20. Crimmins EM, Beltrán-Sánchez H. Mortality and morbidity trends: is there compression of morbidity? J Gerontol B Psychol Sci Soc Sci. 2011;66:75-86. doi:10.1093/geronb/gbq088.
21. Lakdawalla DN, Bhattacharya J, Goldman DP. Are the young becoming more disabled? Health Aff (Millwood). 2004;23:168-176.
22. Bhattacharya J, Cutler DM, Goldman DP, et al. Disability forecasts and future Medicare costs. Front Health Policy Res. 2004;7:75-94.
23. Hulsegge G, Picavet HS, Blokstra A, et al. Today's adult generations are less healthy than their predecessors: generation shifts in metabolic risk factors: The Doetinchem Cohort Study. Eur J Prev Cardiol. 2014;21:1134- 1144. doi:10.1177/2047487313485512.
24. U.S. Department of Health and Human Services NIoH, National Institute of Aging. 90+ in the United States: 2006-2008. US Department of Commerce; 2010.
25. Meeker MG. Technology and system incentives as major drivers of cost. USA, Inc: A basic summary of America's financial statements. Kleiner Perkins Caufield & Byer; 2011.
26. Shortell SM, Gillies R, Siddique J, et al. Improving chronic illness care: A longitudinal cohort analysis of large physician organizations. Med Care. 2009;47:932-939. doi:10.1097/MLR.0b013e31819a621a.
27. (U.S.) CfDCaP. Trends in Current Cigarette Smoking Among High School Students and Adults, United States, 1965-2011.
28. National Institute for Diabetes DaKD. Overweight and Obesity statistics.
29. Edes T, Kinosian B, Vuckovic NH, Nichols LO, Becker MM, Hossain M. Better access, quality, and cost for clinically complex veterans with home-based primary care. J Am Geriatr Soc. 2014;62:1954- 1961. doi:10.1111/jgs.13030.
30. Eric De Jonge K, Jamshed N, Gilden D, Kubisiak J, Bruce SR, Taler G. Effects of home-based primary care on medicare costs in high-risk elders. J Am Geriatr Soc. 2014;62:1825-1831. doi:10.1111/jgs.12974.
31. Boling PA, Leff B. Comprehensive longitudinal health care in the home for high-cost beneficiaries: A critical strategy for population health management. J Am Geriatr Soc. 2014;62:1974-1976. doi:10.1111/jgs.13049.
32. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156.
33. Rockwood K. What is frailty and how can it be conceptualized? J Intell Disabil Res. 2012;56:661-661.
34. Mohler MJ, Fain MJ, Wertheimer AM, Najafi B, Nikolich-Zugich J. The Frailty syndrome: clinical measurements and basic underpinnings in humans and animals. Exp Gerontol. 2014;54:6-13. doi:10.1016/j.exger.2014.01.024.
35. Bartke A. Single-gene mutations and healthy ageing in mammals. Philos Trans R Soc Lond B Biol Sci. 2011;366:28-34. doi:10.1098/rstb.2010.0281.
36. Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013;493:338-345. doi:10.1038/nature11861.
37. Baur JA, Ungvari Z, Minor RK, Le Couteur, DG, de Cabo, R. Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov. 2012;11:443-461. doi:10.1038/nrd3738.
38. Lum JJ, DeBerardinis RJ, Thompson CB. Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol. 2005;6:439-448.
39. Morimoto RI, Cuervo AM. Proteostasis and the aging proteome in health and disease. J Gerontol A Biol Sci Med Sci. 2014;69(suppl 1):S33-S38. doi:10.1093/gerona/glu049.
40. Guarente L, Picard F. Calorie restriction- The SIR2 connection. Cell. 2005;120:473-482.
41. Imai S. SIRT1 and caloric restriction: An insight into possible tradeoffs between robustness and frailty. Curr Opin Clin Nutr Metab Care. 2009;12:350-356. doi:10.1097/MCO.0b013e32832c932d.
42. Barzilai N, Huffman DM, Muzumdar RH, Bartke A. The critical role of metabolic pathways in aging. Diabetes. 2012;61:1315-1322. doi:10.2337/db11-1300.
43. Colman RJ, Anderson RM, Johnson SC, et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009;325:201-204. doi:10.1126/science.1173635.
44. Mattison JA, Roth GS, Beasley TM, et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature. 2012;489:318-321. doi:10.1038/nature11432.
45. Mercken EM, Carboneau BA, Krzysik-Walker SM, de Cabo, R. Of mice and men: The benefits of caloric restriction, exercise, and mimetics. Ageing Res Rev. 2012;11:390-398. doi:10.1016/j.arr.2011.11.005.
46. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460:392-395.
47. Wilkinson JE, Burmeister L, Brooks SV, et al. Rapamycin slows aging in mice. Aging Cell. 2012;11:675-682.
48. Neff F, Flores-Dominguez D, Ryan DP, et al. Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest. 2013;123:3272- 3291. doi:10.1172/JCI67674.
49. Goldberg EL, Romero-Aleshire MJ, Renkema KR, et al. Lifespanextending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms. Aging Cell. 2015;14:130-138. doi:10.1111/acel.12280.
50. Goldberg EL, Smithey MJ, Lutes LK, Uhrlaub JL, Nikolich-Žugich J. Immune memory-boosting dose of rapamycin impairs macrophage vesicle acidification and curtails glycolysis in effector CD8 cells, impairing defense against acute infections. J Immunol. 2014;193:757-763. doi:10.4049/jimmunol. 1400188.
51. Rozengurt E. Mechanistic target of rapamycin (mTOR): A point of convergence in the action of insulin/IGF-1 and G protein-coupled receptor agonists in pancreatic cancer cells. Front Physiol. 2014;5:357. doi:10.3389/fphys.2014.00357.
52. Yates SC, Zafar A, Hubbard P, et al. Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease. Acta Neuropathol Commun. 2013;1:3. doi:10.1186/2051-5960-1-3.
53. Martin-Montalvo A, Mercken EM, Mitchell SJ, et al. Metformin improves healthspan and lifespan in mice. Nat Commun. 2013;4:2192. doi:10.1038/ncomms3192.
54. Sansoni P, Vescovini R, Fagnoni FF, et al. New advances in CMV and immunosenescence. Exp Gerontol. 2014;55:54-62. doi:10.1016/j.exger.2014.03.020.
55. Grant R, Youm YH, Ravussin A, Dixit VD. Quantification of adipose tissue leukocytosis in obesity. Methods Mol Biol. 2013;1040:195-209. doi:10.1007/978-1-62703-523-1-15.
56. Youm YH, Grant RW, McCabe LR, et al. Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab. 2013;18:519-532. doi:10.1016/j.cmet.2013.09.010.
57. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012;488:178-184.doi:10.1038/nature11319.
58. Claesson MJ, Cusack S, O'Sullivan O, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A. 2011;108(suppl 1):4586-4591. doi:10.1073/pnas.1000097107.
59. Campisi J. Between Scylla and Charybdis: p53 links tumor suppression and aging. Mech Ageing Dev. 2002;123:567-573.
60. Qu T, Yang H, Walston JD, Fedarko NS, Leng SX. Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine. 2009;46:319-324. doi:10.1016/j.cyto.2009.02.015.
61. Tchkonia T, Zhu Y, Van Deursen, J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J Clin Invest. 2013;123:966-972. doi:10.1172/JCI64098.
62. Anisimov VN, Bartke A, Barzilai N, et al. The second international conference "genetics of aging and longevity". Aging (Albany NY). 2012;4:305- 317.
63. Ayyadevara S, Bharill P, Dandapat A, et al. Aspirin inhibits oxidant stress, reduces age- Associated functional declines, and extends lifespan of Caenorhabditis elegans. Antioxid Redox Signal. 2013;18:481-490. doi:10.1089/ars.2011.4151.
64. Guarente L. Aging research-where do we stand and where are we going? Cell. 2014;159:15-19. doi:10.1016/j.cell.2014.08.041.
65. Miller RA, Harrison DE, Astle CM, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011;66:191-201. doi:10.1093/gerona/glq178.
66. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342.
67. Faragher RG, Burton DG, Majecha P, et al. Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts. Age (Dordr). 2011;33:555-564. doi:10.1007/s11357-010-9201-5.
68. Miller RA. Genetic approaches to the study of aging. J Am Geriatr Soc. 2005;53:S284-S286.